secwatch.observer — SEC 8-K summary
======================================

Issuer:     RETRACTABLE TECHNOLOGIES INC (RVP)
CIK:        0000946563
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001104659-24-062057
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Retractable Technologies Q1 net sales fall to $7.6M; operating loss widens to $3.0M
--------------------------------------------------------------------------------

- Net sales $7.6M, down 31% from $11.0M in Q1 2023 due to lack of COVID vaccine syringe sales.
- Operating loss $3.0M vs $2.7M; loss widened despite 12.9% decrease in operating expenses.
- Domestic sales rose 22.5% to $6.6M; international sales fell 82.8% to $1.0M.
- Unrealized gain on investments of $1.7M impacted net income; provision for income taxes $86K.
- New 50% tariff on syringes/needles expected in Q3 2024; over 90% of products sourced from China.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946563/000110465924062057/0001104659-24-062057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946563/000110465924062057/tm2414541d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-062057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer